Ireland
--:--IST
Active, not recruiting Observational

Comparison Between ROLL Versus Magnetic Seed for Preoperative Localization of Non-palpable Breast Lesion by Randomized Clinical Study.

NCT05942118 · tracked via the Priya Life Science Italy tracker
Phase
Observational
Started
2023-05-31
Last updated
2026-06-23

Condition(s) studied

Breast Cancer

Investigational drug(s) / intervention(s)

Breast conservative surgery

Breast conservative surgery: Every patients with non-palpable breast lesion will undergo to conservative breast surgery after lesion's localization

Study summary

Several localization techniques are now in use for localization of non-palpable breast lesions. Several studies have compared wire guided localization (WGL), which has been for years the gold standard for non-palpable breast lesions' localization, with more modern techniques. Scientific evidence supports the efficacy of the new "wire-free" techniques, which appear to be comparable to the WGL in terms of safe surgical resection, while overcoming limitations associated with logistic difficulties and patient discomfort. There is still limited data in literature on the comparative effectiveness of these modern techniques, and there is no strong evidence that one is superior to the others. In particular, no randomized trials of comparison between ROLL and magnetic seed localization are currently available. The aim of this randomized study is to compare ROLL with magnetic seed to assess their efficacy for non-palpable breast lesions' localization.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
85 Years
Healthy volunteers
No
Inclusion Criteria: * Female; * Non-palpable breast lesions; * Indication to lesion's surgical excision (lumpectomy, quadrantectomy) * Preoperative diagnosis on histology or cytology of borderline lesion (B3 or C3) or malignant lesion (B4-B5 or C4-C5); * Written informed consent. Exclusion Criteria: * Benign lesion at diagnosis on preoperative core biopsy (B2) or fine needle aspiration (C2); * Clinically palpable breast lesion; * Breast lesion localization for planned neoadjuvant chemotherapy.

Primary outcome measure(s)

  • Free-surgical margins — 3 years
    Number of surgical procedures in which surgical margins are disease-free ("no ink on tumor" for invasive cancer and margin of 2 mm for in situ-carcinoma).

Trial sites (1)

FacilityCityRegionStatus
Istituti Clinici Scientifici Maugeri SpA Pavia Lombardy
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05942118 on ClinicalTrials.gov ↗ ← All trials in Italy